Pharmaceutics · 2023 · 13 citations · 65 references
Life SciencesImmunologyInnate ImmunityVaccine ImmunologyVaccinologyAdjuvant DesignAdjuvant DevelopmentPreclinical Vaccine EvaluationVaccinationVaccine DevelopmentVaccine ReactogenicityAdjuvant DeliveryAdjuvant Design For VaccinesAnimal Model AnalysisAnimal Model EvaluationImmunogenicity ScreeningImmunological AdjuvantsVaccine Adjuvant DevelopmentVaccine-associated Reactogenicity
Adjuvants are a critical component of vaccines. Adjuvants typically target receptors that activate innate immune signaling pathways. Historically, adjuvant development has been laborious and slow, but has begun to accelerate over the past decade. Current adjuvant development consists of screening for an activating molecule, formulating lead molecules with an antigen, and testing this combination in an animal model. There are very few adjuvants approved for use in vaccines, however, as new candidates often fail due to poor clinical efficacy, intolerable side effects, or formulation limitations. Here, we consider new approaches using tools from engineering to improve next-generation adjuvant discovery and development. These approaches will create new immunological outcomes that will be evaluated with novel diagnostic tools. Potential improved immunological outcomes include reduced vaccine reactogenicity, tunable adaptive responses, and enhanced adjuvant delivery. Evaluations of these outcomes can leverage computational approaches to interpret "big data" obtained from experimentation. Applying engineering concepts and solutions will provide alternative perspectives, further accelerating the field of adjuvant discovery.
65
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun, Jiaxi Wu, Fenghe Du et al. · Science · 2012 · 4.8K citations
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Fumihiko Ishikawa, Masaki Yasukawa, Bonnie Lyons et al. · Blood · 2005 · 920 citations · Full text
Life Sciences, Immunology, Pathology +15